Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 380391, 9 pages
http://dx.doi.org/10.1155/2012/380391
Review Article

Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus

Division of Hematology and Stem Cell Transplantation, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy

Received 9 March 2012; Revised 6 June 2012; Accepted 3 July 2012

Academic Editor: Roberto Caricchio

Copyright © 2012 Alberto M. Marmont du Haut Champ. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Marmont, “New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation,” Annual Review of Medicine, vol. 51, pp. 115–134, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. R. K. Burt and A. M. Marmont, Eds., Stem Cell Therapy for Autoimmune Disease, Landes Biosciences, Georgetown, Tex, USA, 2004.
  3. A. M. Marmont, “Will hematopoietic stem cell transplantation cure human autoimmune diseases?” Journal of Autoimmunity, vol. 30, no. 3, pp. 145–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. K. Burt, Y. Loh, W. Pearce et al., “Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases,” Journal of the American Medical Association, vol. 299, no. 8, pp. 925–936, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Ikehara, Ed., “The use of bone marrow transplantation to treat autoimmune disease,” Journal of Autoimmunity, vol. 30, no. 3, pp. 105–196, 2008. View at Publisher · View at Google Scholar
  6. A. M. Marmont, “Treating autoimmune diseases: is stem cell therapy the future?” International Journal of Clinical Rheumatology, vol. 4, no. 4, pp. 395–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Farge, M. Labopin, A. Tyndall et al., “Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European group for blood and marrow transplantation working party on autoimmune diseases,” Haematologica, vol. 95, no. 2, pp. 284–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Sullivan, P. Muraro, and A. Tyndall, “Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.,” Biology of Blood and Marrow Transplantation, vol. 16, no. 1, pp. S48–56, 2010. View at Google Scholar · View at Scopus
  9. J.A. Snowden, R. Saccardi, M. Allez et al., “Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European group for blood and marrow transplantation,” Bone Marrow Transplantation, vol. 47, no. 6, pp. 770–790, 2012. View at Publisher · View at Google Scholar
  10. D. Jayne, J. Passweg, A. Marmont et al., “Autologous stem cell transplantation for systemic lupus erythematosus,” Lupus, vol. 13, no. 3, pp. 168–176, 2004. View at Google Scholar · View at Scopus
  11. R. K. Burt, A. Traynor, L. Statkute et al., “Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus,” Journal of the American Medical Association, vol. 295, no. 5, pp. 527–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Marmont and R. Burt, “Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases,” Autoimmunity, vol. 41, no. 8, pp. 639–647, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Illei, R. Cervera, R. K. Burt et al., “Current status and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 70, no. 12, pp. 2071–2074, 2011. View at Google Scholar
  14. L. Statkute, A. Traynor, Y. Oyama et al., “Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation,” Blood, vol. 106, no. 8, pp. 2700–2709, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Bianco, M. Riminucci, S. Gronthos, and P. G. Robey, “Bone marrow stromal stem cells: nature, biology, and potential applications,” Stem Cells, vol. 19, no. 3, pp. 180–192, 2001. View at Google Scholar · View at Scopus
  16. A. Uccelli, G. Mancardi, and S. Chiesa, “Is there a role for mesenchymal stem cells in autoimmune diseases?” Autoimmunity, vol. 41, no. 8, pp. 592–595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Ankrum and J. M. Karp, “Mesenchymal stem cell therapy: two steps forward, one step back,” Trends in Molecular Medicine, vol. 16, no. 5, pp. 203–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Liang, H. Zhang, B. Hua et al., “Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study,” Annals of the Rheumatic Diseases, vol. 69, no. 8, pp. 1423–1429, 2010. View at Publisher · View at Google Scholar
  19. L. Sun, D. Wang, J. Liang et al., “Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 62, no. 8, pp. 2467–2475, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Zhang, A. M. Bertucci, R. Ramsey-Goldman, R. K. Burt, and S. K. Datta, “Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-β-producing CD8+ Treg cells are associated with immunological remission of lupus,” Journal of Immunology, vol. 183, no. 10, pp. 6346–6358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Marmont, “Historical perspective and rationale of HSCT for autoimmune diseases,” in Stem Cell Therapy for Autoimmune Disease, R. K. Burt and A. M. Marmont, Eds., pp. 223–231, Landes Biosciences, Georgetown, Tex, USA, 2004. View at Google Scholar
  22. A. M. Denman, A. S. Russell, and E. J. Denman, “Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains.,” Clinical and Experimental Immunology, vol. 5, no. 6, pp. 567–595, 1969. View at Google Scholar · View at Scopus
  23. J. I. Morton and B. V. Siegel, “Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H 2 histocompatible recipients of bone marrow from New Zealand black mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 6, pp. 2162–2165, 1974. View at Google Scholar · View at Scopus
  24. S. Smith-Berdan, D. Gille, I. L. Weissman, and J. L. Christensen, “Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells,” Blood, vol. 110, no. 4, pp. 1370–1378, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Reininger, T. Radaszkiewicz, M. Kosco, F. Melchers, and A. G. Rolink, “Development of autoimmune disease in SCID mice populated with long-term 'in vitro' proliferating (NZB x NZW)F1 pre-B cells,” Journal of Experimental Medicine, vol. 176, no. 5, pp. 1343–1353, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ikehara, “Treatment of autoimmune diseases by hematopoietic stem cell transplantation,” Experimental Hematology, vol. 29, no. 6, pp. 661–669, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ikehara, “Stem cell transplantation for autoimmune diseases: what can we learn from experimental models?” Autoimmunity, vol. 41, no. 8, pp. 563–569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. M. Marmont, “Coincidental autoimmune disease in patients transplanted for conventional indications,” Best Practice and Research, vol. 17, no. 2, pp. 223–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Marmont, “Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidence,” Bone Marrow Transplantation, vol. 38, no. 1, pp. 1–4, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. D. W. Van Bekkum, “Preclinical experiments,” Best Practice and Research, vol. 17, no. 2, pp. 201–222, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. M. Marmont, “Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus?” Lupus, vol. 2, no. 3, pp. 151–156, 1993. View at Google Scholar · View at Scopus
  32. A. M. Marmont, A. Gratwohl, T. Vischer, and A. Tyndall, “Haemopoietic precursors cell transplant for autoimmune diseases,” The Lancet, vol. 345, p. 978, 1995. View at Google Scholar
  33. A. Tyndall and A. Gratwohl, “Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT),” Bone Marrow Transplantation, vol. 19, no. 7, pp. 643–645, 1997. View at Google Scholar · View at Scopus
  34. L. M. Griffith, S. Z. Pavletic, A. Tyndall et al., “Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005,” Biology of Blood and Marrow Transplantation, vol. 11, no. 11, pp. 862–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Gratwohl, “Allogeneic hematopoietic stem cell transplantation for severe autoimmune diseases,” Autoimmunity, vol. 41, no. 8, pp. 673–678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Daikeler, T. Hügle, D. Farge et al., “Allogeneic hematopoietic SCT for patients with autoimmune diseases,” Bone Marrow Transplantation, vol. 44, no. 1, pp. 27–33, 2009. View at Publisher · View at Google Scholar
  37. S. Z. Pavletic, “Nonmyeloablative allogeneic hematopoietic stem cell transplantation for autoimmune disease,” Arthritis and Rheumatism, vol. 50, no. 8, pp. 2387–2390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Elhasid, M. B. Arush, I. Zaidman et al., “Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis,” Biology of Blood and Marrow Transplantation, vol. 13, no. 3, pp. 329–338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. A. V. Vanikar, P. R. Modi, R. D. Patel et al., “Hematopoietic stem cell transplantation in autoimmune diseases: the Ahmedabad experience,” Transplantation Proceedings, vol. 39, no. 3, pp. 703–708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Sykes and B. Nikolic, “Treatment of severe autoimmune disease by stem-cell transplantation,” Nature, vol. 435, no. 7042, pp. 620–627, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. F. R. Appelbaum, “Haematopoietic cell transplantation as immunotherapy,” Nature, vol. 411, no. 6835, pp. 385–389, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Slavin, A. Nagler, G. Varadi, and R. Or, “Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis,” Experimental Hematology, vol. 28, no. 7, pp. 853–857, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Hinterberger, M. Hinterberger-Fischer, and A. Marmont, “Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases,” Bone Marrow Transplantation, vol. 30, no. 11, pp. 753–759, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Van Wijmeersch, B. Sprangers, O. Rutgeerts et al., “Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect,” Biology of Blood and Marrow Transplantation, vol. 13, no. 6, pp. 627–637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Chakrabarti, S. K. Handa, R. J. Bryon, M. J. Griffiths, and D. W. Milligan, “Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?” Transplantation, vol. 72, no. 2, pp. 340–342, 2001. View at Google Scholar · View at Scopus
  46. R. K. Burt, Y. Oyama, L. Verda et al., “Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism,” Arthritis and Rheumatism, vol. 50, no. 8, pp. 2466–2470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. R. M. Lowenthal, H. Francis, and D. S. Gill, “Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant,” Journal of Rheumatology, vol. 33, no. 4, pp. 812–813, 2006. View at Google Scholar · View at Scopus
  48. M. Gur-Lavi, “Long-term remission with allogenic bone marrow transplantation in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 42, no. 8, p. 1777, 1999. View at Google Scholar · View at Scopus
  49. R. J. R. McKendry, L. Huebsch, and B. Leclair, “Progression of rheumatoid arthritis following bone marrow transplantation: a case report with a 13-year followup,” Arthritis and Rheumatism, vol. 39, no. 7, pp. 1246–1253, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Tapprich, R. Fenk, P. Schneider, A. Bernhardt, R. Haas, and G. Kobbe, “Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma,” Bone Marrow Transplantation, vol. 32, no. 6, pp. 629–631, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Marmont, F. Gualandi, M. T. van Lint, and A. Bacigalupo, “Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect,” Bone Marrow Transplantation, vol. 31, no. 5, pp. 399–402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. A. M. Marmont, A. Dominietto, F. Gualandi, G. Piaggio, M. T. van Lint, and A. Bacigalupo, “Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLIs,” Biology of Blood and Marrow Transplantation, vol. 12, no. 9, pp. 987–989, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. Marmont, F. Gualandi, D. Occhini et al., “Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome,” Autoimmunity, vol. 39, no. 6, pp. 505–511, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Bregante, F. Gualandi, M. T. van Lint, A. Schenone, A. Bacigalupo, and A. M. Marmont, “Sjögren's syndrome associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) treated with autologous and subsequently allogeneic HSCT. Remission of CIDP, cure of supervened severe aplastic anemia (SAA), but persistence of antinuclear antibodies five years after allogeneic transplantation”.
  55. B. F. Hoyer, R. A. Manz, A. Radbruch, and F. Hiepe, “Long-lived plasma cells and their contribution to autoimmunity,” Annals of the New York Academy of Sciences, vol. 1050, pp. 124–133, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Radbruch, G. Muehlinghaus, E. O. Luger et al., “Competence and competition: the challenge of becoming a long-lived plasma cell,” Nature Reviews Immunology, vol. 6, no. 10, pp. 741–750, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. C. C. Goodnow, “Multistep pathogenesis of autoimmune disease,” Cell, vol. 130, no. 1, pp. 25–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. K. H.-T. Nguyen, J. Brayer, S. Cha et al., “Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 43, no. 10, pp. 2307–2315, 2000. View at Publisher · View at Google Scholar
  59. Y. Loh, Y. Oyama, L. Statkute et al., “Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used,” Blood, vol. 109, no. 6, pp. 2643–2648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Bohgaki, T. Atsumi, and T. Koike, “Multiple autoimmune diseases after autologous stem-cell transplantation,” New England Journal of Medicine, vol. 357, no. 26, pp. 2734–2736, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Daikeler, M. Labopin, M. Di Gioia et al., “Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party,” Blood, vol. 118, no. 6, pp. 1693–1698, 2011. View at Publisher · View at Google Scholar
  62. E. Rossi, G. Catania, M. Truini, G. L. Ravetti, L. Grassia, and A. M. Marmont, “Patients with systemic lupus erythematosus having developed malignant lymphomas. Complete long-terms remission of lymphoma following high-dose chemotherapy, but not of SLE,” Clinical and Experimental Rheumatology, vol. 39, no. 3, pp. 555–559, 2011. View at Google Scholar
  63. A. Tyndall, “Allogeneic bone marrow transplantation for autoimmune disease: the jury is still out,” Journal of Rheumatology, vol. 33, no. 4, pp. 644–646, 2006. View at Google Scholar · View at Scopus
  64. A. M. Marmont, M. T. Van Lint, F. Gualandi, and A. Bacigalupo, “Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration,” Lupus, vol. 6, no. 6, pp. 545–548, 1997. View at Google Scholar · View at Scopus
  65. R. K. Burt, A. Traynor, and R. Ramsey-Goldman, “Hematopoietic stem-cell transplantation for systemic lupus erythematosus [3],” New England Journal of Medicine, vol. 337, no. 24, pp. 1777–1778, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Fouillard, N. C. Gorin, J. P. Laporte, A. Leon, J. F. Brantus, and P. Miossec, “Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood,” Lupus, vol. 8, no. 4, pp. 320–323, 1999. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Brunner, H. T. Greinix, K. Redlich et al., “Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: a case report,” Arthritis and Rheumatism, vol. 46, no. 6, pp. 1580–1584, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Musso, F. Porretto, A. Crescimanno et al., “Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans Syndrome,” Lupus, vol. 7, no. 7, pp. 492–494, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Trysberg, I. Lindgren, and A. Tarkowski, “Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus,” Annals of the Rheumatic Diseases, vol. 59, no. 3, pp. 236–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. F. G. Lehnhardt, C. Scheid, U. Holtik et al., “Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction,” Lupus, vol. 15, no. 4, pp. 240–243, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. S. H. Woolf and J. N. George, “Evidence-based medicine: interpreting studies and setting policy,” Hematology/Oncology Clinics of North America, vol. 14, no. 4, pp. 761–784, 2000. View at Google Scholar · View at Scopus
  72. A. M. Marmont and R. Burt, “Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases,” Autoimmunity, vol. 41, no. 8, pp. 639–647, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. I. Colmegna and C. M. Weyand, “Haematopoietic stem and progenitor cells in rheumatoid arthritis,” Rheumatology, vol. 50, no. 2, Article ID keq298, pp. 252–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. H. A. Papadaki, “Autoreactive T-lymphocytes are implicated in the pathogenesis of bone marrow failure in patients with systemic lupus erythematosus,” Leukemia and Lymphoma, vol. 44, no. 8, pp. 1301–1307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. H. A. Papadaki, M. Tsagournisakis, V. Mastorodemos et al., “Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis,” Bone Marrow Transplantation, vol. 36, no. 12, pp. 1053–1063, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. R. K. Burt, A. Fassas, J. A. Snowden et al., “Collection of hematopoietic stem cells from patients with autoimmune diseases,” Bone Marrow Transplantation, vol. 28, no. 1, pp. 1–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Statkute, L. Verda, Y. Oyama et al., “Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation,” Bone Marrow Transplantation, vol. 39, no. 6, pp. 317–329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Saccardi and F. Gualandi, “Hematopoietic stem cell transplantation procedures,” Autoimmunity, vol. 41, no. 8, pp. 570–576, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. D. Talaulikar, K. E. Tymms, I. Prosser, and R. Smith, “Autologous peripheral blood stem cell transplantation with in vivo T-cell depletion for life threatening refractory systemic lupus erythematosus,” Lupus, vol. 14, no. 2, pp. 159–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Petri, R. J. Jones, and R. A. Brodsky, “High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 48, no. 1, pp. 166–173, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. R. A. Brodsky and R. J. Jones, “Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages,” Autoimmunity, vol. 41, no. 8, pp. 596–600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. H. M. Vriesendorp, “Aims of conditioning,” Experimental Hematology, vol. 31, no. 10, pp. 844–854, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Gratwohl, J. Passweg, C. Bocelli-Tyndall et al., “Autologous hematopoietic stem cell transplantation for autoimmune diseases,” Bone Marrow Transplantation, vol. 35, no. 9, pp. 869–879, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. R. K. Burt, A. Traynor, L. Statkute et al., “Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus,” Journal of the American Medical Association, vol. 295, no. 5, pp. 527–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. R. K. Burt, A. Marmont, Y. Oyama et al., “Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens,” Arthritis and Rheumatism, vol. 54, no. 12, pp. 3750–3760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. R. K. Burt, A. Testor, R. Craig, B. Cohen, R. Suffit, and W. Barr, “Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?” Journal of Autoimmunity, vol. 30, no. 3, pp. 116–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Moore, D. Ma, R. Will, P. Cannell, M. Handel, and S. Milliken, “A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation,” Bone Marrow Transplantation, vol. 34, no. 3, pp. 241–247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Itoh, T. Kano, C. Nagashio, A. Mimori, M. Kinoshita, and M. Sumiya, “Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 54, no. 3, pp. 1020–1022, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. K. R. Carson, A. M. Evens, E. A. Richey et al., “Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project,” Blood, vol. 113, no. 20, pp. 4834–4840, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. G. G. Illei, “Hematopoietic stem cell transplantation in autoimmune diseases:is the glass half full or half empty?” Arthritis and Rheumatism, vol. 54, no. 12, pp. 3730–3734, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. A. M. Marmont and R. Saccardi, “Concluding remarks,” Autoimmunity, vol. 41, no. 8, pp. 686–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. R. K. Burt, Y. Loh, W. Pearce et al., “Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases,” Journal of the American Medical Association, vol. 299, no. 8, pp. 925–936, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. Y. L. Shevchenko, A. A. Novik, A. N. Kuznetsov et al., “High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis,” Experimental Hematology, vol. 36, no. 8, pp. 922–928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. A. M. Marmont, F. Gualandi, M. T. Van Lint, C. Guastoni, and A. Bacigalupo, “Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation,” Lupus, vol. 15, no. 1, pp. 44–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Aschwanden, T. Daikeler, K. A. Jaeger et al., “Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease,” Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 1057–1059, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. G. L. Mancardi, R. Saccardi, M. Filippi et al., “Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS,” Neurology, vol. 57, no. 1, pp. 62–68, 2001. View at Google Scholar · View at Scopus
  97. R. Elhasid, J. M. Rowe, D. Berkowitz, M. Ben-Arush, R. Bar-Shalom, and R. Brik, “Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease,” Bone Marrow Transplantation, vol. 33, no. 12, pp. 1257–1259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. F. Verrecchia, J. Laboureau, O. Verola et al., “Skin involvement in scleroderma-where histological and clinical scores meet,” Rheumatology, vol. 46, no. 5, pp. 833–841, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. P. A. Muraro and D. C. Douek, “Renewing the T cell repertoire to arrest autoimmune aggression,” Trends in Immunology, vol. 27, no. 2, pp. 61–67, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. P. Muraro, “Restoring self-tolerance: lessons from the clinic,” Bone Marrow Transplant, vol. 45, pp. 1–52, 2010. View at Google Scholar
  101. I. De Kleer, B. Vastert, M. Klein et al., “Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+ CD25+ immune regulatory network,” Blood, vol. 107, no. 4, pp. 1696–1702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. F. van Wijk, S. T. Roord, B. Vastert, I. de Kleer, N. Wulffraat, and B. J. Prakken, “Regulatory T cells in autologous stem cell transplantation for autoimmune disease,” Autoimmunity, vol. 41, no. 8, pp. 585–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Abrahamsson and P. A. Muraro, “Immune re-education following autologous hematopoietic stem cell transplantation,” Autoimmunity, vol. 41, no. 8, pp. 577–584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. T. Alexander, A. Thiel, O. Rosen et al., “Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system,” Blood, vol. 113, no. 1, pp. 214–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Alexander, A. Thiel, O. Rosen et al., “Development of antinuclear antibodies with new specifities in systemic lupus erythematosus after autologous hematopoietic stem cell transplantation suggests de novo development of disease rather than lupus reactivation,” Bone Marrrow Transplantat, vol. 43, supplement 1, p. 272, 2009. View at Google Scholar
  106. H. Amital and Y. Shoenfeld, “Autoimmunity and autoimmune diseases,” in Systemic Lupus Erythematosus, R. Lahita, Ed., pp. 2–27, Elsevier, Amsterdam, The Netherlands, 2004. View at Google Scholar
  107. F. Van Wijk, S. T. Roord, B. Vastert, I. de Kleer, N. Wulffraat, and B. J. Prakken, “Regulatory T cells in autologous stem cell transplantation for autoimmune disease,” Autoimmunity, vol. 41, no. 8, pp. 585–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. W. Sun, U. Popat, G. Hutton et al., “Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis,” Brain, vol. 127, no. 5, pp. 996–1008, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. J. Storek, Z. Zhao, Y. Liu, R. Nash, P. McSweeney, and D. G. Maloney, “Early recovery of CD4+ T cell receptor diversity after “Lymphoablative” conditioning and autologous CD34+ cell transplantation,” Biology of Blood and Marrow Transplantation, vol. 14, no. 12, pp. 1373–1379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. T. Mondria, C. H. J. Lamers, P. A. W. Te Boekhorst, J. W. Gratama, and R. Q. Hintzen, “Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 9, pp. 1013–1015, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. F. Hiepe, T. Dörner, and G. R. Burmester, “Editorial overview: antinuclear antibody- and extractable nuclear antigen-related diseases,” International Archives of Allergy and Immunology, vol. 123, no. 1, pp. 5–9, 2000. View at Google Scholar · View at Scopus
  112. P. Eggleton, R. Haigh, and P. G. Winyard, “Consequence of neo-antigenicity of the 'altered self',” Rheumatology, vol. 47, no. 5, pp. 567–571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Crow, “Development in the clinical understanding of lupus,” Arthritis Research & Therapy, vol. 11, pp. 950–960, 2009. View at Google Scholar
  114. F. Alderuccio, J. Chan, and B. H. Toh, “Tweaking the immune system: gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease,” Autoimmunity, vol. 41, no. 8, pp. 679–685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. R. Ramsey-Goldman and A. E. Clarke, “Double trouble: are lupus and malignancy associated?” Lupus, vol. 10, no. 6, pp. 388–391, 2001. View at Publisher · View at Google Scholar · View at Scopus